Global Irritable Bowel Syndrome Treatment Market By Type (IBS-D, IBS-C, IBS-S, and IBS-U), By Drug Class (Linzess/Constella, Xifaxan, Viberzi, Amitiza, and Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Others), By Region, and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025-2034
- Published date: March 2025
- Report ID: 143132
- Number of Pages: 206
- Format:
-
-
-
- Allergan plc
- Takeda Pharmaceutical Company Limited
- Ironwood Pharmaceuticals Inc.
- Synergy Pharmaceuticals Inc.
- Salix Pharmaceuticals Inc.
- Ardelyx Inc.
- Astellas Pharma Inc.
- Lexicon Pharmaceuticals Inc.
- Sebela Pharmaceuticals Inc.
- RedHill Biopharma Ltd.
- Pfizer Inc Company Profile
- Probi AB
Our Clients
✖
Request a Sample Report
We'll get back to you as quickly as possible